Arvee Laboratories (India) Limited Total Assets
Arvee Laboratories (India) Limited total assets. Based on the latest financial reports, Arvee Laboratories (India) Limited (ARVEE) holds total assets worth Rs405.81 Million INR (≈ $4.39 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ARVEE market cap for the company's overall valuation and market capitalisation.
Total Assets of Arvee Laboratories (India) Limited (2013–2025)
Total assets of Arvee Laboratories (India) Limited from 2013 to 2025. This chart illustrates how Arvee Laboratories (India) Limited's total assets have evolved over time, based on quarterly financial data. See ARVEE share price today for real-time trading data and today's change.
Arvee Laboratories (India) Limited - Asset Composition Analysis
Arvee Laboratories (India) Limited Total Assets Breakdown (March 2025)
Arvee Laboratories (India) Limited total assets breakdown as of March 2025. Arvee Laboratories (India) Limited's total assets of Rs405.81 Million consist of 57.1% current assets and 42.9% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs57.64 Million | 0.6% |
| Accounts Receivable | Rs83.98 Million | 22.0% |
| Inventory | Rs45.54 Million | 11.9% |
| Property, Plant & Equipment | Rs159.96 Million | 41.9% |
| Intangible Assets | Rs23.00K | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Arvee Laboratories (India) Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Arvee Laboratories (India) Limited's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Arvee Laboratories (India) Limited's current assets represent 57.1% of total assets in 2025, a decrease from 62.3% in 2013.
- Cash Position: Cash and equivalents constituted 0.6% of total assets in 2025, up from 0.1% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is property, plant & equipment at 41.9% of total assets.
Arvee Laboratories (India) Limited Competitors by Total Assets
Key competitors of Arvee Laboratories (India) Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Akzo Nobel NV
AS:AKZA
|
Netherlands | €13.95 Billion |
|
MITSU.CH.GRP ADR/5
F:M3C0
|
Germany | €5.88 Trillion |
|
LB Group Co Ltd
SHE:002601
|
China | CN¥63.89 Billion |
|
Hubei Feilihua Quartz Glass Co Ltd
SHE:300395
|
China | CN¥8.17 Billion |
|
Beijing Oriental Yuhong Waterproof Technology Co Ltd
SHE:002271
|
China | CN¥43.20 Billion |
|
Luxi Chemical Group Co Ltd
SHE:000830
|
China | CN¥35.95 Billion |
|
5N Plus Inc.
TO:VNP
|
Canada | CA$519.27 Million |
|
Zhejiang Runtu Co Ltd
SHE:002440
|
China | CN¥11.83 Billion |
Arvee Laboratories (India) Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.52 | 3.49 | 1.29 |
| Quick Ratio | 1.84 | 2.93 | 0.88 |
| Cash Ratio | 0.00 | 1.14 | 0.00 |
| Working Capital | Rs172.50 Million | Rs171.48 Million | Rs61.18 Million |
Arvee Laboratories (India) Limited - Advanced Valuation Insights
This section examines the relationship between Arvee Laboratories (India) Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.73 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -0.1% |
| Total Assets | Rs381.58 Million |
| Market Capitalization | $25.75 Million USD |
Valuation Analysis
Below Book Valuation: The market values Arvee Laboratories (India) Limited's assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Arvee Laboratories (India) Limited's assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Arvee Laboratories (India) Limited (2013–2025)
The table below shows the annual total assets of Arvee Laboratories (India) Limited from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs381.58 Million ≈ $4.13 Million |
-0.11% |
| 2024-03-31 | Rs381.99 Million ≈ $4.13 Million |
-1.26% |
| 2023-03-31 | Rs386.85 Million ≈ $4.18 Million |
+0.00% |
| 2022-03-31 | Rs386.85 Million ≈ $4.18 Million |
-5.75% |
| 2021-03-31 | Rs410.46 Million ≈ $4.44 Million |
+22.07% |
| 2020-03-31 | Rs336.25 Million ≈ $3.64 Million |
-9.49% |
| 2019-03-31 | Rs371.49 Million ≈ $4.02 Million |
-15.79% |
| 2018-03-31 | Rs441.17 Million ≈ $4.77 Million |
+23.66% |
| 2017-03-31 | Rs356.75 Million ≈ $3.86 Million |
+1.32% |
| 2016-03-31 | Rs352.10 Million ≈ $3.81 Million |
+35.27% |
| 2015-03-31 | Rs260.29 Million ≈ $2.81 Million |
+49.40% |
| 2014-03-31 | Rs174.22 Million ≈ $1.88 Million |
+95.59% |
| 2013-03-31 | Rs89.07 Million ≈ $963.30K |
-- |
About Arvee Laboratories (India) Limited
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more